1529 related articles for article (PubMed ID: 29996343)
21. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
Tan X; Xie P; Liu J; Wu H; Xie Y
Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
[TBL] [Abstract][Full Text] [Related]
22. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
Huang M; Lin Q; Wang H; Chen J; Bai M; Wang L; Zhu K; Jiang Z; Guan S; Li Z; Qian J; Li M; Pang P; Shan H
Eur Radiol; 2016 Oct; 26(10):3428-36. PubMed ID: 26792430
[TBL] [Abstract][Full Text] [Related]
23. Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.
Sun JH; Zhou T; Zhu T; Zhang Y; Nie C; Ai J; Zhou G; Zhang A; Dong MJ; Wang WL; Zheng SS
Biomed Res Int; 2016; 2016():3048261. PubMed ID: 27999793
[TBL] [Abstract][Full Text] [Related]
24. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
[TBL] [Abstract][Full Text] [Related]
25. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
Long J; Zheng JS; Sun B; Lu N
Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
[TBL] [Abstract][Full Text] [Related]
26. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
28. [Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined therapy with sorafenib for hepatocellular carcinoma with main portal vein tumor thrombus].
Li WW; Dai ZY; Wan HG; Yao LZ; Zhu J; Li CL; Wang XJ; Pan J; Chen LZ
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1838-42. PubMed ID: 27356794
[TBL] [Abstract][Full Text] [Related]
29. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma.
Hong D; Zhou Y; Wan X; Su H; Shao H
BMC Cancer; 2021 Sep; 21(1):1020. PubMed ID: 34521375
[TBL] [Abstract][Full Text] [Related]
30. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
Tao ZW; Cheng BQ; Zhou T; Gao YJ
Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
[TBL] [Abstract][Full Text] [Related]
31. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma.
Takano M; Kokudo T; Miyazaki Y; Kageyama Y; Takahashi A; Amikura K; Sakamoto H
World J Gastroenterol; 2016 Nov; 22(42):9445-9450. PubMed ID: 27895433
[TBL] [Abstract][Full Text] [Related]
32. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib.
Meng XC; Chen BH; Huang JJ; Huang WS; Cai MY; Zhou JW; Guo YJ; Zhu KS
World J Gastroenterol; 2018 Jan; 24(4):484-493. PubMed ID: 29398869
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
34. Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis.
Wang K; Guo WX; Chen MS; Mao YL; Sun BC; Shi J; Zhang YJ; Meng Y; Yang YF; Cong WM; Wu MC; Lau WY; Cheng SQ
Medicine (Baltimore); 2016 Mar; 95(11):e3015. PubMed ID: 26986115
[TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial.
Yang M; Fang Z; Yan Z; Luo J; Liu L; Zhang W; Wu L; Ma J; Yang Q; Liu Q
J Cancer Res Clin Oncol; 2014 Feb; 140(2):211-9. PubMed ID: 24374800
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization.
Liang H; Cui P; Guo Q; Mao X; Wen F; Sun W; Shan M; Lu Z
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e331-e341. PubMed ID: 28078806
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of portal vein stent and TACE combined therapy with or without endovascular implantation of iodine-125 seeds strand for treating patients with hepatocellular carcinoma and main portal vein tumor thrombus].
Wu LL; Luo JJ; Yan ZP; Wang JH; Wang XL; Zhang XB; Fang ZT; Zhang W
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):915-9. PubMed ID: 23522253
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib
Hu HT; Luo JP; Cao GS; Li Z; Jiang M; Guo CY; Yuan H; Yao QJ; Geng X; Park JH; Cheng HT; Jiang L; Ma JL; Zhao Y; Li HL
Front Oncol; 2021; 11():806907. PubMed ID: 35004330
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
40. Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.
Lu J; Guo JH; Ji JS; Li YL; Lv WF; Zhu HD; Sun JH; Ren WX; Zhang FJ; Wang WD; Shao HB; Cao GS; Li HL; Gao K; Yang P; Yin GW; Zhu GY; Wu FZ; Wang WJ; Lu D; Chen SQ; Min J; Zhao Y; Li R; Lu LG; Lau WY; Teng GJ
Int J Surg; 2023 May; 109(5):1188-1198. PubMed ID: 37038986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]